Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
Mult Scler Relat Disord
; 27: 412-418, 2019 Jan.
Article
em En
| MEDLINE
| ID: mdl-30530071
Palavras-chave
APC, antigen-presenting cell; Abbreviations: ADCC, antibody-dependent cellular cytotoxicity; Aqp4, aquaporin 4; Aquaporin-4; BAFF, b-cell activating factor; BBB, blood-brain barrier; BCR, b cell receptor; CDD, complement-dependent cytotoxicity; CFA, complete freund's adjuvant; CSF, cerebrospinal fluid; CXCL, c-x-c motif chemokine ligand; EAE, experimental autoimmune encephalomyelitis; ECD, extracellular domain; Experimental animal models; IGG, immunoglobulin g; IVMP, methylprednisolone pulse; LETM, longitudinally extensive transverse myelitis; MAB, monoclonal antibody; MBP, myelin-binding protein; MOG, myelin oligodendrocyte glycoprotein; MOG-Ab, anti-MOG antibody; NF-H, neurofilament heavy chain; NMO, neuromyelitis optica; NMO-IgG, NMO with serum AQP4-IgG; NMOSD, NMO spectrum disorder; Neuromyelitis optica; Neuromyelitis optica spectrum disorder; PB, plasmablast; PP, plasmapheresis; Remyelination
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neuromielite Óptica
/
Modelos Biológicos
Tipo de estudo:
Etiology_studies
/
Prognostic_studies
Limite:
Animals
/
Humans
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article